Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen Therapy for Central Sensitization
NCT02025686Completed
- Start
- Mar 2012
- Primary completion
- Aug 2012
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Randomised, open-label trial of hyperbaric oxygen therapy in hyperalgesia, inflammation and pain. Primary endpoint: Area of Secondary Hyperalgesia at 8 weeks. Started Mar 2012; status: completed.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
hyperalgesiainflammationpain
Beyond the preview
Go deeper on NCT02025686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025686.